Skip to main content
Log in

Chiral HPLC analysis of venlafaxine metabolites in rat liver microsomal preparations after LPME extraction and application to an in vitro biotransformation study

  • Original Paper
  • Published:
Analytical and Bioanalytical Chemistry Aims and scope Submit manuscript

Abstract

A three-phase LPME (liquid-phase microextraction) method for the enantioselective analysis of venlafaxine (VF) metabolites (O-desmethylvenlafaxine (ODV) and N-desmethylvenlafaxine (NDV) in microsomal preparations is described for the first time. The assay involves the chiral HPLC separation of drug and metabolites using a Chiralpak AD column under normal-phase mode of elution and detection at 230 nm. The LPME procedure was optimized using multifactorial experiments and the following optimal condition was established: sample agitation at 1,750 rpm, 20 min of extraction, acetic acid 0.1 mol/L as acceptor phase, 1-octanol as organic phase and donor phase pH adjustment to 10.0. Under these conditions, the mean recoveries were 41% and 42% for (−)-(R)-ODV and (+)-(S)-ODV, respectively, and 47% and 48% for (−)-(R)-NDV and (+)-(S)-NDV, respectively. The method presented quantification limits of 200 ng/mL and it was linear over the concentration range of 200–5,000 ng/mL for all analytes. The validated method was employed to study the in vitro biotransformation of VF using rat liver microsomal fraction. The results demonstrated the enantioselective biotransformation of VF.

Chromatogram showing the chiral metabolites N-desmethylvenlafaxine (peaks 3 and 4) and O-desmethylvenlafaxine (peaks 5 and 6) formed from the biotransformation of venlafaxine (peaks 1 and 2) in rat liver microsomes

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Liu W, Cai H, Li H (2007) J Chromatogr B 850:405–411

    Article  CAS  Google Scholar 

  2. Fanali S, Rudaz S, Veuthey JL, Desiderio C (2001) J Chromatogr A 919:195–203

    Article  CAS  Google Scholar 

  3. Ciusani E, Zullino DF, Eap CB, Brawand-Amey M, Brocard M, Baumann P (2004) J Psychopharmacol 18:550–566

    Article  Google Scholar 

  4. Wang CP, Howell SR, Scatina J, Sisenwinw SF (1992) Chirality 4:84–90

    Article  Google Scholar 

  5. Hermann M, Hendset M, Fosaas K, Hjerpset M, Refsum H (2008) Eur J Clin Pharmacol 64:483–487

    Article  CAS  Google Scholar 

  6. Kamath J, Handratta V (2008) Expert Rev Neurother 8:1787–1797

    Article  CAS  Google Scholar 

  7. Gex-Fabry M, Rudaz S, Balant-Gorgia AE, Brachet A, Veuthey JL, Balant LP, Bertschy G (2002) Eur J Clin Pharmacol 58:323–331

    Article  CAS  Google Scholar 

  8. Eap CB, Lessard E, Baumann P, Brawand-Amey M, Yessine MA, O´Hara G, Turgeon J (2003) Pharmacogenetics 13:39–47

    Article  CAS  Google Scholar 

  9. Wen L, Feng W, Huan-de L (2007) J Chromatogr B 850:183–189

    Article  Google Scholar 

  10. Rudaz S, Stella C, Balant-Gorgia AE, Fanali S, Veuthey JL (2000) J Pharm Bio Anal 23:107–115

    Article  CAS  Google Scholar 

  11. Ho TS, Pedersen-Bjergaard S, Rasmussen KE (2006) J Chromatogr Sci 44:308–316

    CAS  Google Scholar 

  12. Da Fonseca P, Freitas LAP, Pinto LFR, Pestana CR, Bonato PS (2008) J Chromatogr B 875:161–167

    Article  Google Scholar 

  13. Pedersen-Bjergaard S, Rasmussen KE (1999) Anal Chem 71:2650–2656

    Article  CAS  Google Scholar 

  14. Psillakis E, Kalogerakis N (2003) Trends Anal Chem 22:565–574

    Article  CAS  Google Scholar 

  15. Rasmussen KE, Pedersen-Bjergaard S (2004) Trends Anal Chem 23:1–10

    Article  CAS  Google Scholar 

  16. De Oliveira ARM, Magalhães IRS, De Santana FJM, Bonato PS (2008) Quim Nova 31:637–644

    Google Scholar 

  17. Lake BG (1987) In: Snell K, Mullock B (eds.) Biochemical toxicology—a practical approach, Oxford, Washington

  18. Zhao L, Zhu L, Lee HK (2002) J Chromatogr A 963:239–248

    Article  CAS  Google Scholar 

  19. Pedersen-Bjergaard S, Rasmussen KE (2005) J Chromatogr B 817:3–12

    Article  CAS  Google Scholar 

  20. Andersen S, Halvorsen TG, Pedersen-Bjergaard S, Rasmussen KE (2002) J Chromatogr A 963:303–312

    Article  CAS  Google Scholar 

  21. FDA—Guidance for industry: bioanalytical methods validation (May 2001)

  22. Brandon EFA, Raap CD, Meijerman I, Beijnen JH, Schellens JHM (2003) Toxicol Appl Pharmacol 189:233–246

    Article  CAS  Google Scholar 

  23. Tingle MD, Helsby NA (2006) Environ Toxicol Pharmacol 21:184–190

    Article  CAS  Google Scholar 

  24. Riley RJ, Grime K (2004) Drug Discov Today 1:365–372

    CAS  Google Scholar 

Download references

Acknowledgments

The authors are grateful to Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) and Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) for granting financial support and research fellowships.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pierina Sueli Bonato.

Rights and permissions

Reprints and permissions

About this article

Cite this article

da Fonseca, P., Bonato, P.S. Chiral HPLC analysis of venlafaxine metabolites in rat liver microsomal preparations after LPME extraction and application to an in vitro biotransformation study. Anal Bioanal Chem 396, 817–824 (2010). https://doi.org/10.1007/s00216-009-3271-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00216-009-3271-1

Keywords

Navigation